SMAD4 and familial pancreatic carcinoma: Additionally, loss of Smad4 staining was a significant prognostic marker for a poor outcome in different cancers (cervical carcinoma, colorectal cancer, gastric cancer and pancreatic cancer), regardless of the number of participants (small or large).